Science Translational Medicine · 2021 · 37 citations · 54 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsRegulatory T CellsTumor Immune MicroenvironmentTumor-infiltrating LymphocytesImmune Checkpoint Blockade ResistancePeripheral Regulatory T CellsRegulatory T Cell DepletionRegulatory T Cell RecruitmentT Cell Checkpoint InhibitionTumor Microenvironment Effects
Persistent T cell receptor stimulation drives neuropilin-1 on intratumoral regulatory T cells, which is associated with poor clinical outcome.
54
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text
Medicine, Oncology, Metastasis +5
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text